|
gi protectants |
|
glucose-dependent insulinotropic polypeptide (GIP) receptor agonists |
|
glucosylceramide synthase inhibitors |
|
glutamate receptor antagonists |
|
|
|
glycylcyclines |
|
|
|
|
|
|
|
calcium channel blockers (dihydropyridine) |
|
|
|
carbamates |
|
|
|
|
|
carbohydrates |
|
|
|
|
|
|
|
ccr5 co.receptor antagonists |
|
CD4-directed post-attachment HIV-1 inhibitor |
|
|
|
chloride channel activators |
|
|
|
|
|
cholinergics, muscarinic agonists, sialagogues |
|
|
|
cholinergics (cholinesterase inhibitors), n methyl d aspartate antagonist |
|
cholinesterase reactivators |
|
colloids |
|
complement.inhibitors |
